TechU Ventures — Full Portfolio
17 tracked investments · listed companies and verified rows first
Liberum develops cell-free protein expression systems spanning bacterial, yeast, insect and mammalian biology, turning generated sequences into physical proteins and measured data.
AI & Machine LearningBiotechDeep Tech
Aidan Tinafar(Founder)in
Co-investorsSOSVJude Gomila
Arpeggio Bio is a pharmaceutical company that uses AI and high-throughput RNA-sequencing to develop drugs targeting transcription factors, including historically "undruggable" proteins such as NRF2, TEAD, and GPX4.
AI & Machine LearningBiotechDeep TechHealthtechBoulder, US
Joey Azofeifa(Founder)inLaura Norris(Executive Officer, Director)inTimothy Read(Executive Officer, Director)Eric Martin(Executive Officer)in
BoardAmit Mehta(Director)
Co-investorsATEM Capital FundFifty YearsFundersClubTau VenturesvenBio PartnersY Combinator+9 more
Autonomous is an AI-powered wealth management platform that provides integrated financial management across investments, taxes, planning, and execution for high-net-worth individuals with complex financial situations.
AI & Machine LearningFintechNew York City, US
Dillon Erb(Founder/CEO)inDaniel Kobran(Founder/COO)inChris Swart(CFO)Jen Keller(Chief of Staff)
Co-investorsBoxGroupCollaborative FundHAWKTAILY CombinatorAAL VCAlt Capital+7 more
Ayar Labs develops co-packaged optics (CPO) technology for AI infrastructure, enabling optical connectivity between thousands of GPUs across data center racks.
AI & Machine LearningDeep TechHardwareSemiconductorsSan Jose, US
Mark Wade(Founder)inAlex Wright-Gladstein(Founder)inChen Sun(Founder)Milos Popovic(Founder)Rajeev Ram(Founder)Vladimir Stojanovic(Founder)
Co-investorsNVIDIAAlumni VenturesAxevil CapitalBasecamp FundBerkeley FrontierBlue Bear Ventures+29 more
Boulder-based preclinical biotech using human-cell directed evolution to create target-degrading antibodies and next-generation ADCs.
Boulder, US
Doug Chapnick(Founder)in
BoardJoel Dudley(Director)inNicholas Saccomano(Director)
Co-investorsBoxOne VenturesHorizons VenturesInnovation EndeavorsBoom Capital Ventures
Cactus automates lead response and customer re-engagement for home service businesses, ensuring calls are answered within 60 seconds and dormant CRM contacts are converted into repeat bookings.
AI & Machine LearningEnterprise SoftwareSaaSSan Francisco, US
Ajith Govind(CEO)inAvinash Joshi(CTO)inWendy Moore(Recruiting)
Co-investorsBlast.ClubGaingelsInvestorXMaiora Rebel VenturesMarketplaceMK Venture Capital+29 more
Cranston builds AI agents that automate back-office work for CPA firms, including tax preparation, bookkeeping, and client follow-up processes.
AI & Machine LearningEnterprise SoftwareFintechSaaSSan Francisco, US
Sean O'Bannon(Founder/CTO)inMax Minsker(Founder/CEO)in
Co-investorsRebel FundScript CapitalTranspose Platform ManagementY CombinatorAmino CapitalAndreessen Horowitz+11 more
Destinus develops the Hornet Block 2, a mobile canister-launched dual-role system that intercepts subsonic aerial threats and conducts precision strikes against maritime and ground targets.
Advanced ManufacturingAI & Machine LearningDeep TechDefense TechHardwareRobotics
Mikhail Kokorich(Founder)in
Co-investorsblueworld.groupCathexis VenturesConny & Co.MK Venture CapitalNazcaOne Way Ventures+5 more
Duranium develops reactor technology that modernizes carbochlorination metallurgy to produce titanium, magnesium, aluminum, zirconium, and hafnium with reduced emissions and lower costs while securing critical minerals for U.S. manufacturing independence.
Advanced ManufacturingCleantechNew MaterialsRoboticsSan Francisco, US
Brenden Prins-McKinney(Founder/CEO)inBerkley Noble(Founder/CTO)inMalik Salamatian(BizDevOps)
Co-investorsFundersClubStartXY CombinatorAgrolimen VenturesBand of AngelsClose Quarters Capital+2 more
Mesh automates accruals accounting for finance teams by extracting transaction data from accounts payable systems and communication platforms to generate audit-ready entries, reducing manual month-end close work.
AI & Machine LearningEnterprise SoftwareFintechSan Francisco, US
Erin Kim(Founder/CEO)inNandini Ramakrishnan(Founder)inSethu Chandra(Recruiting Coordinator)Kunal Mundada(Founding Engineer)
Co-investorsMaiora Rebel VenturesMK Venture CapitalRebel FundY CombinatorAmino CapitalCarnegie Mellon University+10 more
Multiply Labs develops cloud-controlled modular robotic systems that manufacture individualized drugs and deploys them in pharmaceutical customers' facilities, selling robotic production capacity as a service.
Advanced ManufacturingBiotechDeep TechRoboticsSan Francisco, US
Fred Parietti(CEO)inAlice Melocchi(CSO)inNaveen Jain(Investor)inJoe Wilson(COO)Tiffany Kuo(Head of Marketing and Operations)Zack Bright(Lead Robotics Engineer)
Co-investorsFifty YearsGarage CapitalJude GomilaLingottoP101 VenturesStrange Ventures+16 more
Naveris develops and commercializes liquid biopsy tests for the early detection and monitoring of HPV-associated cancers, particularly head and neck and anal cancers.
BiotechData & InfrastructureDigital HealthHealthtechMedical DevicesWaltham, US
James McNally(Executive Officer, Director)inPiyush Gupta(Executive Officer, Director)
BoardAnne Stone(Director)Francis Crispino(Director)Philip Grahame Haydon(Director)
Co-investorsBrightEdgeGurnet Point Capital
Nomic offers an end-to-end protein profiling service built on its nELISA technology, quantifying up to 1000 informative proteins with absolute quantification for research studies.
BiotechDeep TechHealthtechMedical DevicesMontreal, CA
Milad Dagher(Founder)inJeff Munzar(Founder)inElisha Krauss(Operations Manager)Ani Muradyan(Recruiter)
Co-investors2048 VenturesAmplitude Venture CapitalAvant BioFirst Star VenturesFront Row VenturesRaptor Group+9 more
Portal develops a universal cell engineering platform designed to expand the biological potential of cell therapies and improve their accessibility for research and therapeutic applications.
BiotechDeep TechHealthtechArlington, US
Armon Sharei(Founder)in
Co-investorsIKJ CapitalPear VCScaleGood Fund LP (powered by TELUS)Undeterred CapitalIA VenturesNFX
RreviveMed applies artificial intelligence to metabolomics and biology to support drug discovery in the pharmaceutical and biotech sector.
AI & Machine LearningBiotechHealthtechCambridge, US
Leila Pirhaji(Co-Founder & CEO)inAndrey Zarur(Director)inCarlos Gonzalez(Director)Ernest Fraenkel(Co-founder & Board Member)in
Co-investorsGood Growth CapitalHalf Court VenturesMassChallenge MexicoTeam Builder VenturesWorldQuant Ventures
Sydecar provides a platform for fund managers to form and operate venture funds, including SPV formation, compliance tools (KYC, tax filings, reporting), and investor onboarding for co-investment opportunities.
Enterprise SoftwareFintechHouston, US
Nikhil Talreja(Executive Officer, Director)Nik Talreja(Founder)inDavid Meister(Founder)
BoardDaniel Kimerling(Director)inStephanie Hsieh(Director)
Co-investorsAnthemis VentureBlank Space VenturesDeciensHawke VenturesHustle FundLoftyInc Capital+6 more
Volumetric builds living multicellular human tissues using 3D bioprinting technology that creates complex blood vessel networks, primarily to produce patient-specific tissues for drug safety and efficacy testing, basic biology research, and screening.
BiotechDeep TechHealthtechMedical DevicesHouston, US
Jordan Miller(Co-founder)inBagrat Grigoryan(Co-founder)in
Co-investorsGaingelsGoAhead VenturesHarmonix FundHelios CapitalJoyance PartnersJude Gomila+21 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
























__Twitter.png)







-2.png)
















































